1. A heterozygous germline CD100 mutation in a family with primary sclerosing cholangitis
- Author
-
Kjetil Taskén, Kimia T. Maleki, Sigrid S. Skånland, Jon K. Laerdahl, Andre Franke, Britt-Sabina Löscher, Espen Melum, Annika Bergquist, Tom H. Karlsen, Martin Cornillet, Niklas K. Björkström, Xiaojun Jiang, Kristian Holm, Geetha Venkatesh, and Jeff E. Mold
- Subjects
0301 basic medicine ,T-Lymphocytes ,T cell ,Cholangitis, Sclerosing ,Semaphorins ,Biology ,medicine.disease_cause ,Germline ,Primary sclerosing cholangitis ,Pathogenesis ,Interferon-gamma ,Mice ,03 medical and health sciences ,0302 clinical medicine ,Antigens, CD ,Interferon ,medicine ,Homologous chromosome ,Animals ,Missense mutation ,Gene Knock-In Techniques ,Germ-Line Mutation ,Mutation ,General Medicine ,medicine.disease ,Germ Cells ,030104 developmental biology ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Cancer research ,medicine.drug - Abstract
Primary sclerosing cholangitis (PSC) is a chronic inflammatory liver disease without clear etiology or effective treatment. Genetic factors contribute to PSC pathogenesis, but so far, no causative mutation has been found. We performed whole-exome sequencing in a family with autosomal dominant inheritance of PSC and identified a heterozygous germline missense mutation in SEMA4D, encoding a K849T variant of CD100. The mutation was located in an evolutionarily conserved, unstructured cytosolic region of CD100 affecting downstream signaling. It was found to alter the function of CD100-expressing cells with a bias toward the T cell compartment that caused increased proliferation and impaired interferon-γ (IFN-γ) production after stimulation. Homologous mutation knock-in mice developed similar IFN-γ impairment in T cells and were more prone to develop severe cholangitis when exposed to 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC) diet. Transfer of wild-type T cells to knock-in mice before and during DDC exposure attenuated cholangitis. Taken together, we identified an inherited mutation in the disordered cytosolic region of CD100 resulting in T cell functional defects. Our findings suggest a protective role for T cells in PSC that might be used therapeutically.
- Published
- 2021
- Full Text
- View/download PDF